Treeline Biosciences, Inc.
Clinical trials sponsored by Treeline Biosciences, Inc., explained in plain language.
-
New hope for tough lymphoma: experimental drug TLN-254 enters human testing
Disease control Recruiting nowThis early-stage trial tests an experimental drug called TLN-254 in about 50 adults with T-cell lymphoma that has returned or not responded to prior therapy. The main goal is to see if the drug can shrink tumors or make them disappear. Researchers will also monitor side effects a…
Phase: PHASE1 • Sponsor: Treeline Biosciences, Inc. • Aim: Disease control
Last updated May 17, 2026 02:07 UTC
-
New hope for tough lymphomas: experimental drug TLN-121 enters human testing
Disease control Recruiting nowThis early-stage trial is testing a new drug called TLN-121, alone or with other treatments, in about 180 people whose Non-Hodgkin Lymphoma has returned or not responded to prior therapies. The main goals are to check the drug's safety and how the body processes it, while also lo…
Phase: PHASE1 • Sponsor: Treeline Biosciences, Inc. • Aim: Disease control
Last updated May 17, 2026 02:06 UTC
-
New drug TLN-372 targets tough KRAS cancers in early trial
Disease control Recruiting nowThis early-phase study tests a new drug called TLN-372 in people with advanced solid tumors that have a KRAS mutation. The goal is to check the drug's safety, how it moves through the body, and whether it can shrink tumors when used alone or with other cancer drugs. About 240 adu…
Phase: PHASE1 • Sponsor: Treeline Biosciences, Inc. • Aim: Disease control
Last updated May 14, 2026 12:02 UTC